A. Wells (London, United Kingdom), A. Prasse (Freiburg, Germany)
Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis
V. Capelozzi, R. Moutinho, E. Parra, A. P. Velosa, C. de Oliverira, W. Teodoro, N. Yoshinari (São Paulo, Brazil)
|   |
Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma
W. Teodoro, D. dos Anjos, A. P. Velosa, C. de Oliveira, E. Parra, N. Yoshinari, V. Capelozzi (São Paulo, Brazil)
| |
Arterial type V collagen disorganization in patients with systemic sclerosis: preliminary study
E. Parra, W. Teodoro, V. Capelozzi (São Paulo, Brazil)
| |
Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis
R. Souza, W. Teodoro, S. Carrasco, R. Kairalla, C. Borges, C. Goldenstein-Schainberg, E. Parra, E. Carvalho, E. Bonfa, N. Yoshinari, V. Capelozzi (Sao Paulo, Brazil)
| |
Minimal skin involvement in systemic sclerosis does not preclude pulmonary involvement – an analysis of the German Network for Systemic Sclerosis (DNSS) Registry
L. Hanitsch, C. Witt, R. Gabriele (Berlin, Germany)
| |
Pulmonary hemorrhage onset of systemic diseases
A. Demin (Novosibirsk, Russian Federation)
| |
Significance of connective tissue disease in a typical UK diffuse parenchymal lung disease clinic
M. Thornber, A. Millar (Bristol, United Kingdom)
| |
Clinico-radiological-pathological features of MPO-ANCA-positive interstitial pneumonia
K. Hashimoto, T. Ogura, A. Hebisawa, Y. Kawabata, F. Sakai, T. Kanauchi, S. Kuramochi, M. Yoshida, H. Taniguchi, D. Tokunaga, T. Yamaguchi, W. Matsuyama, Y. Nasuhara, S. Abe, T. Saito, H. Yoshizawa, K. Chida, E. Shimizu (Tottori, Tokyo, Japan)
| |
Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity?
M. Romagnoli, S. Tomassetti, G. Casoni, M. Chilosi, A. Carloni, V. Poletti (Forlì, Verona, Terni, Italy)
| |
MRI findings in alveolar proteinosis. Comparison with HRCT findings
M. Pougounias, I. Lambiri, K. Pagonidis, D. Vassilakis, G. Maltezakis, A. Karantanas, N. Siafakas (Herakion, Heraklion, Greece)
| |
Evaluation of Behcet‘s disease patients who admitted with pulmonary symptoms (analysis of 14 cases)
G. Camsari, G. Ozkan, A. Gur, D. Bakan, S. Bes, M. Bayram, A. Kulcu (Istanbul, Turkey)
| |
Pulmonary Langerhans‘-cell histiocytosis – clinical futures and outcome
E. Radzikowska, E. Wiatr, P. Remiszewski, I. Bestry, R. Langfort, I. Hawrylkiewicz, K. Roszkowski (Warsaw, Poland)
| |
Lymphangioleiomyomatosis – an analysis of 4 cases
I. N. Belaconi, C. L. Toma, C. E. Tudose, S. Dumitrache-Rujinski, D. Bumbacea, V. Ghinescu, M. A. Bogdan (Bucharest, Romania)
| |
Treatment of lymphangioleiomyomatosis with anastrozole; a potent and selective non-steroidal aromatase inhibitor
C. Tetikkurt, S. Tetikkurt, K. Cepni, I. Cepni, S. Erkan (Istanbul, Turkey)
| |
Lung function and morphological changes in lymphangioleiomiomatosis (LAM)
M. Kameneva, I. Dvorakovskai, L. Novikova, O. Baranova (Saint-Petersburg, Russian Federation)
| |
The prevalence of respiratory disease in a cohort of patients with systemic lupus erythematosus (SLE) in a large Irish teaching hospital
M. Pallin, J. Kitchen, O. Akin-ajayi, F. O‘Connell, G. Cunnane (Dublin, Ireland)
| |
Electrodiagnostic study of phrenic nerve function in patients with systemic lupus erythematosus
M. Elprince, N. Mahmoud, S. Maher, M. Hefny (Ismailia, Egypt)
| |
Amyotrophic lateral sclerosis (ALS): follow-up respiratory failure
Z. Karakurt, N. Adigüzel, T. Yarkin, G. Güngör, D. Özgül (Istanbul, Turkey)
| |
United airways in cystic fibrosis
R. Chiron, M. Murris-Espin, L. Crampette, M. Varrin, A. Didier, B. Wallaert, P. Chanez, S. Leroy (Montpellier, Toulouse, Nimes, Lille, France)
| |
Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus
S. Cheikh Rouhou, S. Merai, S. BenMrad, S. Yaalaoui, F. Tritar (Ariana, Tunisia)
| |